Index of /ohmr-wordpress-v2/web/app/uploads/2019/10

 NameLast modifiedSizeDescription
 Parent Directory   -  
 hierarchy-three-type..>2020-10-01 18:45 21K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 7.7K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 28K 
 S-Improving-Aborigin..>2020-10-01 18:45 76K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 39K 
 S-The-device-that-en..>2020-10-01 18:45 64K 
 Renee-Rawson-from-Ch..>2020-10-01 18:45 5.6K 
 Cell-signalling-unit..>2020-10-01 18:45 178K 
 S-Improving-Aborigin..>2020-10-01 18:45 116K 
 Cell-signalling-unit..>2020-10-01 18:45 76K 
 S-Improving-Aborigin..>2020-10-01 18:45 17K 
 Renee-Rawson-from-Ch..>2020-10-01 18:45 66K 
 hierarchy-three-type..>2020-10-01 18:45 55K 
 S-translational-rese..>2020-10-01 18:45 156K 
 Cell-signalling-unit..>2020-10-01 18:45 89K 
 Cell-signalling-unit..>2020-10-01 18:45 14K 
 S-Why-curing-rare-di..>2020-10-01 18:45 59K 
 S-Improving-Aborigin..>2020-10-01 18:45 13K 
 Cancer-researchers-o..>2020-10-01 18:45 16K 
 S-translational-rese..>2020-10-01 18:45 43K 
 S-Improving-Aborigin..>2020-10-01 18:45 49K 
 S-How-AI-and-ingenio..>2020-10-01 18:45 16K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 4.2K 
 S-translational-rese..>2020-10-01 18:45 97K 
 S-Why-curing-rare-di..>2020-10-01 18:45 13K 
 S-translational-rese..>2020-10-01 18:45 68K 
 S-translational-rese..>2020-10-01 18:45 19K 
 S-How-AI-and-ingenio..>2020-10-01 18:45 62K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 8.2K 
 Renee-Rawson-from-Ch..>2020-10-01 18:45 12K 
 SOPs-templates-vol-4..>2020-10-01 18:45 367K 
 Tile_Early-Phase-Cli..>2020-10-01 18:45 42K 
 S-Improving-Aborigin..>2020-10-01 18:45 7.4K 
 hierarchy-three-type..>2020-10-01 18:45 148K 
 S-translational-rese..>2020-10-01 18:45 70K 
 Tile_Early-Phase-Cli..>2020-10-01 18:45 20K 
 Cell-signalling-unit..>2020-10-01 18:45 6.9K 
 SOPs-templates-vol-3..>2020-10-01 18:45 1.5M 
 Tile_Early-Phase-Cli..>2020-10-01 18:45 8.0K 
 Cryotank-at-Chris-OB..>2020-10-01 18:45 11K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 41K 
 S-How-AI-and-ingenio..>2020-10-01 18:45 17K 
 Kinghorn-Cancer-Cent..>2020-10-01 18:45 8.4K 
 Vector-lab-at-Chris-..>2020-10-01 18:45 145K 
 S-How-AI-and-ingenio..>2020-10-01 18:45 7.2K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 26K 
 S-How-AI-and-ingenio..>2020-10-01 18:45 123K 
 S-How-AI-and-ingenio..>2020-10-01 18:45 8.5K 
 Renee-Rawson-from-Ch..>2020-10-01 18:45 465K 
 Cryotank-at-Chris-OB..>2020-10-01 18:45 5.8K 
 Cancer-researchers-o..>2020-10-01 18:45 127K 
 Tile_Early-Phase-Cli..>2020-10-01 18:45 28K 
 S-translational-rese..>2020-10-01 18:45 78K 
 S-translational-rese..>2020-10-01 18:45 15K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 20K 
 S-The-device-that-en..>2020-10-01 18:45 4.2K 
 Renee-Rawson-from-Ch..>2020-10-01 18:45 78K 
 SOPs-templates-vol-2..>2020-10-01 18:45 1.4M 
 S-Improving-Aborigin..>2020-10-01 18:45 1.3M 
 S-translational-rese..>2020-10-01 18:45 16K 
 S-Why-curing-rare-di..>2020-10-01 18:45 5.8K 
 Cancer-researchers-o..>2020-10-01 18:45 9.1K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 475K 
 S-The-device-that-en..>2020-10-01 18:45 8.0K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 19K 
 Kinghorn-Cancer-Cent..>2020-10-01 18:45 14K 
 Cryotank-at-Chris-OB..>2020-10-01 18:45 89K 
 SOPs-templates-vol-1..>2020-10-01 18:45 1.4M 
 Cryotank-at-Chris-OB..>2020-10-01 18:45 485K 
 S-The-device-that-en..>2020-10-01 18:45 9.5K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 449K 
 S-The-device-that-en..>2020-10-01 18:45 4.6K 
 Cryotank-at-Chris-OB..>2020-10-01 18:45 73K 
 Tile_Early-Phase-Cli..>2020-10-01 18:45 4.3K 
 Kinghorn-Cancer-Cent..>2020-10-01 18:45 143K 
 Tile_Early-Phase-Cli..>2020-10-01 18:45 474K 
 hierarchy-three-type..>2020-10-01 18:45 44K 
 Tile_Clinical-Trial-..>2020-10-01 18:45 3.7K 
 S-Improving-Aborigin..>2020-10-01 18:45 6.4K 
 S-The-device-that-en..>2020-10-01 18:45 74K 
 2019-PhD-Partnership..>2020-10-01 18:45 464K 
 Vector-lab-at-Chris-..>2020-10-01 18:45 16K 
 Vector-lab-at-Chris-..>2020-10-01 18:45 7.1K